Other Resources

RfP for Supply of UNITAID-Financed Pediatric and/or Adult Second-Line Antiretrovirals (March 2012-February 2013)

10/24/2011 CHAI and UNITAID - RfP for UNITAID-Financed Pediatric and/or Adult Second-Line Antiretrovirals for period of March 2012-February 2013

UNITAID-CHAI Opportunistic Infection RfP FAQs

03/07/2011 CHAI - UNITAID-CHAI OI Supplier Selection Process Supplier Q&A

UNITAID-CHAI Opportunistic Infection RfP Cover Note

03/15/2011 CHAI - Cover Note: "We are pleased to invite you to participate in the June 2011 – February 2012 UNITAID Pediatric Project for the supply of Opportunistic Infection (OI) drugs"

RfP for Supply of UNITAID-Financed Pediatric Opportunistic Infection Drugs (June 2011-February 2012)

02/22/2011 CHAI - RfP Background and Forms for UNITAID-Financed Pediatric OI drugs for period of June 2011-February 2012

RfP for Supply of UNITAID-Financed Pediatric and/or Adult Second-Line Antiretrovirals (March 2011-February 2012)

10/20/2010 - RfP for UNITAID-Financed Pediatric and/or Adult Second-Line Antiretrovirals for period of March 2011 - February 2012

CHAI Drug Quality Policy

08/01/2010 CHAI's Drug Quality Policy

The Control of Malaria 2005-15

02/01/2010 ALL PARTY PARLIAMENTARY GROUP - Malaria disease and deaths have been shown to be falling in several settings. However, this is a “fragile success” with a need for further investment to consolidate and expand the early gains.

UNITAID-CHAI ARV Supplier Selection Process Supplier FAQs

11/09/2009 CHAI - Questions that UNITAID/CHAI has received regarding the recently ARV supplier selection process, together with CHAI’s responses.

Malaria Elimination in Zanzibar: A Feasibility Assessment

10/01/2009 ZANZIBAR MALARIA CONTROL PROGRAM - The Zanzibar Malaria Control Program (ZMCP) is facing an important decision of whether to continue sustaining malaria control or to seek malaria elimination

Methodology for Global Forecast of ACT Demand

05/01/2009 CHAI - In response to needs voiced by the suppliers of artemisinin combination therapies (ACTs) and the international malaria community, the Clinton Foundation HIV/AIDS Initiative (CHAI) developed a forecast of global demand for ACTs, their corresponding active pharmaceutical ingredients (API), and the artemisinin starting material upon which ACTs are based.

Shrinking the Malaria Map: A Guide on Malaria Elimination for Policy Makers

04/01/2009 MALARIA ELIMINATION GROUP - This Guide on Malaria Elimination for Policy Makers provides guidance and high-level technical insight to leaders in governments that are considering or have embarked upon a national or regional strategy of malaria elimination and to the donors, agencies, and others who support them.